The Food and Drug Administration initially authorised the injectable medication for managing diabetes in 2017; the agency approved a drug with an increased dose with the Lively ingredient in copyright, called semaglutide, to treat obesity in 2021, beneath the brand name name Wegovy. Considering the fact that then, speak of the drug has popped up ac